Paving the way to better health in Uganda through innovation
Despite high levels of maternal and infant mortality and other challenges, Uganda has made great strides in improving health. PATH has facilitated many advancements, working closely with the government of Uganda since 2002. Together, we have introduced promising new technologies and interventions to meet Ugandans’ health needs.
Our work in Uganda
Cervical cancer: For more than a decade, PATH has partnered with the government of Uganda to reduce high rates of cervical cancer through prevention, early detection, and treatment. With our support, the Uganda Cancer Institute has become a center of excellence and a regional training center for other African countries.
Uganda was among the first countries in Africa to assess a new HPV DNA test that can use self-collected samples, and we assessed the conditions needed for introduction in Uganda. Additional efforts include fostering development of a regional training center for screening and treatment of precancerous lesions, and analyzing Uganda’s market for precancer treatment equipment.
Vaccines: PATH generates data for the introduction of new vaccines. In Uganda, we studied the optimal way to reach young adolescent girls with a vaccine against human papillomavirus (HPV), the cause of nearly all cervical cancers. Guided by our findings, the Uganda Ministry of Health has since introduced the HPV vaccine and immunized tens of thousands of girls. PATH is also supporting the country to prepare for possible future adoption of a malaria vaccine.
In addition, we provide expert technical guidance to help improve Uganda’s supply chains. Better refrigeration and monitoring technologies, for example, are fundamentally shifting the way vaccines are delivered throughout the country.
Family planning: A key focus of our work is ensuring that women have access to a variety of safe and affordable contraceptive options. PATH is leading the introduction of Sayana® Press, a new formulation and packaging of a popular injectable contraceptive. More than 130,000 doses were administered during the pilot introduction. Hundreds of women also took part in studies on self-injection, which could increase control and access.
Advocacy: PATH helps Ugandan citizens and civil society organizations improve the quality and availability of health and social services by enhancing their capacity to carry out effective advocacy. This work has also been instrumental in developing policy guidelines for product introduction and disease management. Additional focus areas include attainment of global anti-HIV targets, and policies and programs for tuberculosis, family planning, malaria, nutrition, and human resources for health.
Sayana Press is a registered trademark of Pfizer Inc.
Photo: PATH/Will Boase.
The story of Sayana® Press
Sayana Press is increasing access and choice in Africa
How Uganda is beating cervical cancer—and lighting the way for the rest of Africa